Do you want to read an article? Please log in or register.
Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis
PsoriasisRheumatoid Arthritis
Related content
Rheumatoid Arthritis
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Ann Rheum Dis.
Rutherford AI, Subesinghe S, Hyrich KL, Galloway JB
doi: 10.1136/annrheumdis-
COMMENTED
PsoriasisRheumatoid Arthritis
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
doi: 10.1016/S2468-1253(19)30362-0.
Rheumatoid Arthritis
Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents
Clin Exp Rheumatol.
Rodriguez-Rodriguez L, Leon L, Ivorra-Cortes J, Gómez A, Lamas JR1, Pato E, Jover JA, Abásolo L
Rheumatoid Arthritis
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
Ann Rheum Dis.
Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC
doi: 10.1136/annrheumdis-
Rheumatoid Arthritis
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype
Rheumatology (Oxford).
Hellgren K, Di Giuseppe D, Smedby KE, Sundström C, Askling J, Baecklund E
doi: 10.1093/rheumatology/keaa330.
Rheumatoid Arthritis
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).
Ann Rheum Dis.
Smolen JS, Kremer JM, Gaich CL, DeLozier AM, Schlichting DE, Xie L, Stoykov I, Rooney T, Bird P, Sánchez Bursón JM, Genovese MC, Combe B
doi: 10.1136/
Further Publications Rheumatology
Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study
Arthritis Rheumatol
Shalev Rosenthal Y, Schwartz N, Sagy I, Pavlovsky L
doi: 10.1002/art.41946
COMMENTED
Rheumatoid Arthritis
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
doi: 10.1186/s13075-019-2059-8.
Rheumatoid Arthritis
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors
Ann Rheum Dis.
Teitsma XM, Jacobs JWG, Welsing PMJ, de Jong PHP, Hazes JMW, Weel AEAM, Pethö-Schramm A, Borm MEA, van Laar JM, Lafeber FPJG, Bijlsma JWJ
doi: 10.1136/annrheumdis-